467 (Rizatriptan Benzoate (Orally Disintegrating) 5 mg (base))
Pill with imprint 467 is White, Round and has been identified as Rizatriptan Benzoate (Orally Disintegrating) 5 mg (base). It is supplied by Glenmark Generics Inc., USA.
Rizatriptan is used in the treatment of migraine and belongs to the drug class antimigraine agents. Risk cannot be ruled out during pregnancy. Rizatriptan 5 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for 467
Rizatriptan Benzoate (Orally Disintegrating)
- Imprint:
- 467
- Strength:
- 5 mg (base)
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Antimigraine agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Glenmark Generics Inc., USA
- National Drug Code (NDC):
- 68462-0467
More about rizatriptan
- Rizatriptan Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 240 Reviews
- Drug class: antimigraine agents
- FDA Alerts (1)
Consumer resources
- Rizatriptan
- Rizatriptan Orally Disintegrating Tablets
- Rizatriptan Tablets
- Rizatriptan (Advanced Reading)
Other brands: Maxalt, Maxalt-MLT
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
